SDC1 and Miyoshi myopathy: VIS832-induced lower ADCC activity against target JJN3 (Fig. 2a, b) and ANBL6 (Fig. 2a, c) MM cells, presumably due to relatively lower CD138 expression (e.g., relative to levels in H929 or MM1S).